Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation.

@article{Kharazi2011ImpactOG,
  title={Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation.},
  author={Shabnam Kharazi and Adam J Mead and Anna Mansour and Anne Hultquist and Charlotta B{\"o}iers and Sidinh Luc and Natalija Buza-Vidas and Zhi Jian Ma and Helen Ferry and Debbie Atkinson and Kristian Reckzeh and Kristina Masson and J{\"o}rg Cammenga and Lars R{\"o}nnstrand and Fumio Arai and Toshio Suda and Claus Nerlov and Ewa Sitnicka and Sten Eirik W Jacobsen},
  journal={Blood},
  year={2011},
  volume={118 13},
  pages={3613-21}
}
Acquisition of homozygous activating growth factor receptor mutations might accelerate cancer progression through a simple gene-dosage effect. Internal tandem duplications (ITDs) of FLT3 occur in approximately 25% cases of acute myeloid leukemia and induce ligand-independent constitutive signaling. Homozygous FLT3-ITDs confer an adverse prognosis and are frequently detected at relapse. Using a mouse knockin model of Flt3-internal tandem duplication (Flt3-ITD)-induced myeloproliferation, we… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 42 references

Functional analysis of epidermal growth factor receptor (EGFR) mutations and potential implications for EGFR targeted therapy

RK Kancha, N von Bubnoff, C Peschel, J. Duyster
Clin Cancer Res • 2009

Similar Papers

Loading similar papers…